| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0062 |
0.9 |
| mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
0.0064 |
0.9 |
| mRNA |
PF-562271 |
GDSC1000 |
pan-cancer |
AAC |
-0.0057 |
0.9 |
| mRNA |
VX-680 |
GDSC1000 |
pan-cancer |
AAC |
0.009 |
0.9 |
| mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0064 |
0.9 |
| mRNA |
AEW541 |
CCLE |
pan-cancer |
AAC |
0.0074 |
0.9 |
| mRNA |
Bortezomib |
FIMM |
pan-cancer |
AAC |
-0.024 |
0.9 |
| mRNA |
BRD-K03536150 |
CTRPv2 |
pan-cancer |
AAC |
-0.0061 |
0.9 |
| mRNA |
MG-132 |
GDSC1000 |
pan-cancer |
AAC |
-0.0076 |
0.9 |
| mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
0.0052 |
0.9 |